金属硫蛋白和肿瘤增殖抗原在肾癌组织中的表达及意义

目的　探讨金属硫蛋白 (MT)和肿瘤增殖抗原 (Ki 67)在肾癌组织中的表达及意义。　方法　应用免疫组化SABC法检测 5 9例肾癌患者组织标本及 19例正常肾组织标本中MT及Ki 67蛋白表达 ,流式细胞术检测DNA含量及S期比例。　结果　MT在肾癌及正常肾组织中的阳性表达率分别为 5 2 .5 %和 78.9% (P <0 .0 5 ) ;G1表达率高于G2 、G3(P <0 .0 1) ,Ⅰ、Ⅱ期高于Ⅲ、Ⅳ期 (P <0 .0 5 ) ,有无淋巴结转移之间差别有显著性意义 (P <0 .0 1) ,不同直径肿瘤之间差别无显著性意义 (P>0 .0 5 )。MT( )及MT( - )患者术后 5年生存率分别为 5 8.1%和 2 8.6% (P <0 .0 5 )。肾癌组织Ki 67指数高于正常肾组织 (P <0 .0 1) ,且与病理分级、临床分期相关 ;Ki 67指数较高者 ,MT表达率较低 ,MT表达率及Ki 67指数分别与S期比例显著相关。　结论　MT及Ki 67蛋白可能参与肾癌的发生、进展及转移过程 ,可作为肾癌细胞增殖及预后估计的参考指标。

Expression of metallothionein and Ki-67 in renal cell carcinoma

Objective To study the expression of metallothionein(MT),Ki 67 in renal cell carcinoma(RCC) and to evaluate their biological significance. Methods The expression of MT and Ki 67 were assayed by means of immunohistochemical technique in RCC tissues and normal renal tissues.DNA content and S phase fraction(SPF) were measured by flow cytometry(FCM). Results The positive expression rates of MT in RCC tissues and normal renal tissues were 52.5%,78.9% respectively( P <0.05).MT expression was related to tumor grade,stage,lymphatic metastasis and prognosis,but not to tumor size.Ki 67 indexes in RCC tissues were higher than those in normal renal tissues( P <0.01),and were related to clinicopathological parameters.The MT expression was lower.Both the Ki 67 and MT expressions were significantly correlated to SPF. Conclusions MT and Ki 67 may be involved in the process of renal carcinogenesis,tumor progression and metastasis. Their immunoreactivity may serve as parameters of proliferation and prognosis in RCC.